Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy (Q33410771)

26 July 2017

title

Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy (English)

1 reference

inflammatory bowel diseases

26 July 2017

main subject

0 references

Nodular regenerative hyperplasia

1 reference

C O Musumba

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

16 September 2013

1 reference

Alimentary Pharmacology & Therapeutics

26 July 2017

published in

1 reference

26 July 2017

volume

38

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1025-1037

1 reference

Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension

26 July 2017

cites work

1 reference

Nodular regenerative hyperplasia: not all nodules are created equal.

21 January 2018

1 reference

Idiopathic noncirrhotic portal hypertension.

21 January 2018

1 reference

Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases.

21 January 2018

1 reference

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules

21 January 2018

1 reference

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension

21 January 2018

1 reference

Obliterative portal venopathy: portal hypertension is not always present at diagnosis.

21 January 2018

1 reference

Management of hepatic vascular diseases.

21 January 2018

1 reference

Liver transplantation for the treatment of nodular regenerative hyperplasia

21 January 2018

1 reference

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

21 January 2018

1 reference

Radiologic mimics of cirrhosis

21 January 2018

1 reference

Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

21 January 2018

1 reference

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

21 January 2018

1 reference

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

21 January 2018

1 reference

Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review

21 January 2018

1 reference

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

21 January 2018

1 reference

6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.

21 January 2018

1 reference

Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia

21 January 2018

1 reference

Hepatic lesions in patients treated with synthetic anabolic steriods

21 January 2018

1 reference

Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease

21 January 2018

1 reference

Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

Azathioprine induced nodular regenerative hyperplasia in IBD patients.

21 January 2018

1 reference

Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?

21 January 2018

1 reference

Treatment with adalimumab in a patient with regenerative nodular hyperplasia secondary to azathioprine.

21 January 2018

1 reference

Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis

21 January 2018

1 reference

Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease

21 January 2018

1 reference

Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease

21 January 2018

1 reference

Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine

21 January 2018

1 reference

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

21 January 2018

1 reference

Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine

21 January 2018

1 reference

Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.

21 January 2018

1 reference

Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.

21 January 2018

1 reference

Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients

21 January 2018

1 reference

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

21 January 2018

1 reference

Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.

21 January 2018

1 reference

Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts

21 January 2018

1 reference

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment

21 January 2018

1 reference

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

21 January 2018

1 reference

Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease.

21 January 2018

1 reference

Remission maintenance by tioguanine in chronic active Crohn's disease

21 January 2018

1 reference

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease

21 January 2018

1 reference

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

21 January 2018

1 reference

Further experience with the use of 6-thioguanine in patients with Crohn's disease

21 January 2018

1 reference

Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.

21 January 2018

1 reference

6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.

21 January 2018

1 reference

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease

21 January 2018

1 reference

Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience

21 January 2018

1 reference

Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine

21 January 2018

1 reference

The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.

21 January 2018

1 reference

Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).

21 January 2018

1 reference

Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance

21 January 2018

1 reference

Inflammation and thrombosis

21 January 2018

1 reference

Thrombosis and inflammatory bowel disease

21 January 2018

1 reference

Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease

21 January 2018

1 reference

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

21 January 2018

1 reference

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity

21 January 2018

1 reference

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations

21 January 2018

1 reference

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides

21 January 2018

1 reference

Vascular disorders of the liver

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12490

1 reference

26 July 2017

1 reference